Full Disclosure

References

1. Studdert, D., Mello, M.M., Gawande, A., et al. (2006). Claims, errors, and compensation payments in medical malpractice litigation. N Eng J Med, 354, 2024-33.
2. Helmreich, R.L. (2000). On error management: Lessons from aviation. BMJ, 320, 781-5.
3. Merrick, G., Wallner, K., & Butler, W. (2003). Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol, 169,1643-52.
4. Mitsuyama, H., Wallner, K., Merrick, G., et al. (2007). The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy. Am J Clin Onc: In press.
5. Merrick, G., Butler, W., Wallner, K., et al. (2004). Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer. Urology, 64, 754-9.
6. Stock, R.G., Stone, N.N., Cesaaretti, J., et al. (2006). Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and post-treatment biopsy results. Int J Rad Oncol Biol Phys, 64, 527-33.
7. Dattoli, M., Wallner, K., True, L., et al. (2007). Long-term prostate cancer control using Palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension. Urology, 69, 334-7.
8. Merrick, G., Wallner, K., Butler, W., et al. (2006). Brachytherapy in men aged = 54 years with clinically localized prostate cancer. BJU International, 98, 324-8.
9. Zelefsky, M.J., Yamada, Y., Cohen, G., et al. (2007). Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Rad Oncol Biol Phys, 67, 65-70.
10. Wallner, K., Merrick, G., True, L., et al. (2005). 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: Early biochemical outcomes from a prospective randomized multi-center trial. Radiother and Oncol, 75, 307-10.
11. Wallner, K., Merrick, G., True, L., et al. (2003). I-125 versus Pd-103 for low-risk prostate cancer: Preliminary biochemical outcomes from a prospective randomized multicenter trial. Int J Rad Oncol Biol Phys, 57, 1297-303.
12. Elliott, K., Wallner, K., Merrick, G., et al. (2004). Medical malpractice of prostate brachytherapy. Brachytherapy, 3, 231-6.
13. Tran, A., Wallner, K., Merrick, G., et al. (2005). Rectal fistulas following prostate brachytherapy. Int J Rad Oncol Biol Phys, 63, 150-4.
14. Mayadev, J., Wallner, K., Merrick, G., et al. Prostate brachytherapy-related rectal fistulas: Tracking, analyzing and preventing a rare complication. Submitted 2008.
15. Wallner, K.E., Roy, J., & Harrison, L. (1996). Low risk of perioperative infection without prophylactic antibiotics for transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys, 36, 681-3.
16. Zhu, A., Wallner, K., Frivold, G., et al. (2006). Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarction. Brachytherapy, 5, 262-5.
17. Wallner, K., Merrick, G., Blasko, J., et al. (2008). Malpractice. Prostate Brachytherapy Made Complicated, 3rd edition.
18. Snyder, K.M., Stock, R.G., Hong, S.M., et al. (2001). Defining the risk of developing grade 2 proctitis following 125-I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Rad Oncol Biol Phys, 50, 335-41.
19. Herstein, A., Wallner, K., Merrick, G., et al. (2005). I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial. Cancer J, 11, 385-9.
20. Dicker, A.P., Figura, A.T., Waterman, F.M., et al. (2000). Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Techniques in Urology, 6, 104-8.
21. Reed, D., Wallner, K., Merrick, G., et al. (2007). A prospective randomized comparison of stranded versus loose iodine-125 seeds for prostate brachytherapy. Brachytherapy, 6, 129-34.
22. Davis, B., Bresnahan, J., Stafford, S., et al. (2002). Prostate brachytherapy seed migration to a coronary artery found during angiography. J Urol, 168, 1103.